Impact of bladder volume on treatment planning and clinical outcomes of radiotherapy for patients with cervical cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer, version 2.2015. J Natl Compr Canc Netw. 2015;13(4):395–404; quiz 404.
   Web of Science ®Google Scholar
• Linn YH, Thu KK, Win N. Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study. Probiotics Antimicrob Proteins. 2019;11(2):638–647.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang L, Gao L, et al. Radiat Oncol [M]. Beijing: Peking Union Medical University Press. 2018;1406–1409.
   Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010. doi:10.1016/S0140-6736(14)62038-925467588
   PubMed Web of Science ®Google Scholar
• Lin AJ, Kidd E, Dehdashti F, et al. Intensity modulated radiation therapy and image-guided adapted brachytherapy for cervix cancer. Int J Radiat Oncol Biol Phys. 2019;103(5):1088–1097. doi:10.1016/j.ijrobp.2018.11.01230445171
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang F, Hu K, Hou X. Image-guided, intensity-modulated radiation therapy in definitive radiotherapy for 1433 patients with cervical cancer. Gynecol Oncol. 2018;151(3):444–448. doi:10.1016/j.ygyno.2018.09.02430266261
   PubMed Web of Science ®Google Scholar
• Lin Y, Chen K, Lu Z, et al. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis. Radiat Oncol. 2018;13(1):177. doi:10.1186/s13014-018-1126-730217165
   PubMedGoogle Scholar
• Shengnan Cai KH. Advances in the treatment of radiotherapy complications of cervical cancer. Prog Obstet Gynecol. 2014;23(7):574–576.
   Google Scholar
• Lawrence YR, Paulus R, Langer C, et al. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. Lung Cancer. 2013;80(3):298–305. doi:10.1016/j.lungcan.2013.02.00823477890
   PubMed Web of Science ®Google Scholar
• Yamashita H, Nakagawa K, Okuma K, et al. Correlation between bladder volume and irradiated dose of small bowel in CT-based planning of intracavitary brachytherapy for cervical cancer. Jpn J Clin Oncol. 2012;42(4):302–308. doi:10.1093/jjco/hyr20322301719
   PubMed Web of Science ®Google Scholar
• Siavashpour Z, Aghamiri MR, Jaberi R, Manshadi HR, Ghaderi R, Kirisits C. Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. J Contemp Brachytherapy. 2016;8(2):135–142. doi:10.5114/jcb.2016.5968727257418
   PubMed Web of Science ®Google Scholar
• Bandanatham S, Gururajachar JM, Somashekar MK. Compliance with bladder protocol during concurrent chemoradiation for cancer of the cervix and its impact on enteritis: A prospective observational study. Rep Pract Oncol Radiother. 2018;23(2):69–74. doi:10.1016/j.rpor.2017.12.00529681770
   PubMedGoogle Scholar
• Shi D, Zhao Z, He M, et al. Effect of bladder volume change on normal tissue doses in 3D conformal braehytherapy for cervical cancer. Chin J Radiat Oncol. 2015;24(2):159–162.
   Google Scholar
• Patra NB, Manir KS, Basu S, Goswami J, Kabasi AK, Sarkar SK. Effect of bladder distension on dosimetry of organs at risk in computer tomography based planning of high-dose-rate intracavitary brachytherapy for cervical cancer. J Contemp Brachytherapy. 2013;5(1):3–9. doi:10.5114/jcb.2013.3433923634149
   PubMed Web of Science ®Google Scholar
• Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104.19367689
   PubMed Web of Science ®Google Scholar
• Friendlander AH, Ettinger RL. Karnofsky performance status scale. Spec Care Dentist. 2009;29(4):147–148. doi:10.1111/j.1754-4505.2009.00088.x19573040
   PubMedGoogle Scholar
• NCCN. The NCCN Cervical Cancer Clinical Practice Guidelines in Oncology (version 3.2019) [EB/OL]. Fort Washington: NCCN; 2018 12 17.
   Google Scholar
• Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77. doi:10.1016/j.radonc.2005.11.01416403584
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–245. doi:10.1016/j.radonc.2004.12.01515763303
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Thomadsen B. American Brachytherapy Society Cervical Cancer Recommendations Committee, American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012;11(1):33–46. doi:10.1016/j.brachy.2011.07.00322265436
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11(1):47–52. doi:10.1016/j.brachy.2011.07.00222265437
   PubMed Web of Science ®Google Scholar
• Lee LJ, Das IJ, Higgins SA, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy. 2012;11(1):53–57. doi:10.1016/j.brachy.2011.07.00122265438
   PubMed Web of Science ®Google Scholar
• Viswanathan ANKC, Erickson BEPR, editors. Gynecologic Radiation Therapy Novel Approaches to Image-guidance and Management. Berlin (Heidelberg): Springer-Verlag Berlin Heidelberg; 2011.
   Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207–214. doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-67459811
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–1346. doi:10.1016/0360-3016(95)00060-C7713792
   PubMed Web of Science ®Google Scholar
• He M, Liu X. Advances in diagnosis and treatment of recurrent cervical cancer. J Mod Med Health. 2018;34(17):2683–2687.
   Google Scholar
• Atiq A, Atiq M, Iqbal K, et al. A comparative study of RapidArc and intensity-modulated radiotherapy plan quality for cervical cancer treatment. Indian J Cancer. 2018;55(1):74–79. doi:10.4103/ijc.IJC_609_1730147098
   PubMed Web of Science ®Google Scholar
• Jodda A, Piotrowski T, Urbański B, Malicki J. Relations between dose cumulated in organs at risk and treatment based on different image-guidance strategies of cervical cancer. Phys Med. 2019;57:183–190. doi:10.1016/j.ejmp.2019.01.00830738524
   PubMed Web of Science ®Google Scholar
• Peng Q, Peng Y, Zhu J, Cai M, Zhou L. [Accuracy of different image registration methods in image-guided adaptive brachytherapy for cervical cancer]. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(11):1344–1348. doi:10.12122/j.issn.1673-4254.2018.11.1130514683
   PubMedGoogle Scholar
• Simha V, Rai B, Patel FD, et al. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: an institutional experience. Brachytherapy. 2018;17(2):345–351. doi:10.1016/j.brachy.2017.09.00829102740
   PubMed Web of Science ®Google Scholar
• Wang Y, Kong W, Lv N, et al. Incidence of radiation enteritis in cervical cancer patients treated with definitive radiotherapy versus adjuvant radiotherapy. J Cancer Res Ther. 2018;14(Supplement):S120–S124. doi:10.4103/0973-1482.16376229578161
   PubMedGoogle Scholar
• Yang X, Wang J, Lin L, Gao D, Yin L. Concomitant chemoradiotherapy versus pure radiotherapy in locally advanced cervical cancer: a retrospective analysis of complications and clinical outcome. Eur J Gynaecol Oncol. 2016;37(4):499–503.29894074
   PubMed Web of Science ®Google Scholar
• Small W Jr. Potential for use of amifostine in cervical cancer. Semin Oncol. 2002;29(6 Suppl 19):34–37. doi:10.1053/sonc.2002.37366
   PubMed Web of Science ®Google Scholar
• Kuruba V, Gollapalli P. Natural radioprotectors and their impact on cancer drug discovery. Radiat Oncol J. 2018;36(4):265–275. doi:10.3857/roj.2018.0038130630265
   PubMed Web of Science ®Google Scholar
• Lee MG, Freeman AR, Roos DE, Milner AD, Borg MF. Randomized double-blind trial of amifostine versus placebo for radiation-induced xerostomia in patients with head and neck cancer. J Med Imaging Radiat Oncol. 2019;63(1):142–150. doi:10.1111/jmiro.2019.63.issue-130461207
   PubMed Web of Science ®Google Scholar
• Kim RY, Shen S, Lin H-Y, Spencer SA, De Los Santos J. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010;76(2):485–489. doi:10.1016/j.ijrobp.2009.02.00219467797
   PubMed Web of Science ®Google Scholar
• Nesseler JP, Charra-Brunaud C, Salleron J, et al. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer. Brachytherapy. 2017;16(5):976–980. doi:10.1016/j.brachy.2017.06.00328694116
   PubMed Web of Science ®Google Scholar
• Fu T, Xu W,Xu S, et al. Effects of different status of the bladder on dosimetry to normal tissue in brachytherapy of Cervix Cancer: a meta-analysis. Chin J Radiat Oncol. 2016;25(7):718–723.
   Google Scholar
• Pötter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1):116–123. doi:10.1016/j.radonc.2011.07.01221821305
   PubMed Web of Science ®Google Scholar
• Lee H, Huh SJ, Oh D, Jeong BK, Ju SG. Radiation sigmoiditis mimicking sigmoid colon cancer after radiation therapy for cervical cancer: the implications of three-dimensional image-based brachytherapy planning. J Gynecol Oncol. 2012;23(3):197–200. doi:10.3802/jgo.2012.23.3.19722808363
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhao G, Qi J, et al. Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: a retrospective comparison with chemoirradiation. Mol Clin Oncol. 2018;8(4):623–627. doi:10.3892/mco.2018.158029556393
   PubMed Web of Science ®Google Scholar
• Wang YM, Wang CJ, Fang FM, et al. Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - a propensity score-matched study. Gynecol Oncol. 2017;145(2):277–283. doi:10.1016/j.ygyno.2017.02.03428274568
   PubMed Web of Science ®Google Scholar
• Allen S, Kilian C, Phelps J, Whelan HT. The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Support Care Cancer. 2012;20(10):2467–2472. doi:10.1007/s00520-012-1379-x22246598
   PubMed Web of Science ®Google Scholar
• Novetsky AP, Einstein MH, Goldberg GL, et al. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer. Gynecol Oncol. 2007;105(3):635–640. doi:10.1016/j.ygyno.2007.01.03217331568
   PubMed Web of Science ®Google Scholar